Oguzhan Atay Sells 12,500 Shares of Billiontoone (NASDAQ:BLLN) Stock

Posted by Brenda Bartman on Jul 15th, 2026

Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) CEO Oguzhan Atay sold 12,500 shares of Billiontoone stock in a transaction dated Thursday, July 9th. The shares were sold at an average price of $126.10, for a total value of $1,576,250.00. Following the completion of the transaction, the chief executive officer owned 12,500 shares in the company, valued at $1,576,250. This trade represents a 50.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oguzhan Atay also recently made the following trade(s):

On Monday, July 6th, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The stock was sold at an average price of $122.05, for a total value of $1,525,625.00.
On Monday, July 6th, Oguzhan Atay sold 26,250 shares of Billiontoone stock. The stock was sold at an average price of $122.05, for a total value of $3,203,812.50.
On Monday, June 8th, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The stock was sold at an average price of $98.22, for a total value of $1,227,750.00.
On Monday, June 8th, Oguzhan Atay sold 26,250 shares of Billiontoone stock. The stock was sold at an average price of $97.66, for a total value of $2,563,575.00.

Billiontoone Stock Performance

BLLN opened at $124.87 on Wednesday. The company has a market cap of $5.74 billion and a P/E ratio of 227.04. The company has a quick ratio of 10.58, a current ratio of 10.92 and a debt-to-equity ratio of 0.18. The firm’s 50-day moving average price is $102.36 and its 200-day moving average price is $89.36. Billiontoone, Inc. has a 52-week low of $61.96 and a 52-week high of $138.70.

Billiontoone (NASDAQ:BLLN – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The company had revenue of $108.39 million during the quarter, compared to analyst estimates of $95.81 million. The firm’s revenue for the quarter was up 83.8% on a year-over-year basis. During the same quarter last year, the business earned ($0.39) earnings per share. As a group, equities analysts anticipate that Billiontoone, Inc. will post 0.93 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Weiss Ratings raised shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, June 23rd. Guggenheim assumed coverage on Billiontoone in a research report on Monday, June 29th. They set a “buy” rating and a $125.00 price target for the company. BTIG Research dropped their price target on Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research note on Thursday, May 7th. Finally, JPMorgan Chase & Co. increased their price objective on Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Six equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $126.00.

Read Our Latest Report on Billiontoone

Institutional Trading of Billiontoone

Large investors have recently made changes to their positions in the business. Rossby Financial LCC purchased a new position in shares of Billiontoone during the fourth quarter worth $25,000. Wells Fargo & Company MN purchased a new stake in Billiontoone in the fourth quarter valued at $76,000. Smartleaf Asset Management LLC acquired a new stake in Billiontoone during the 4th quarter worth about $80,000. Nano Cap New Millennium Growth Fund L P purchased a new position in shares of Billiontoone during the 4th quarter valued at about $82,000. Finally, Renaissance Capital LLC purchased a new position in shares of Billiontoone during the 4th quarter valued at about $201,000.

About Billiontoone

(Get Free Report)

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.